FDA data Registry peer set 1 peer FDA shortage listed

Alternatives to azelastine

FDA shortage status is active for azelastine; 1 same-class SPL records are listed below for registry comparison only.

Brand: Astelin, Astepro

Antihistamine (Nasal) OTC 1 alternative found

azelastine class peers while FDA lists an active shortage

azelastine (Astelin, Astepro) is on an FDA shortage listing while 1 other Antihistamine (Nasal) SPL records remain in this registry peer set (class inventory 2). Labeled indication field for azelastine: This medicine treats symptoms of seasonal allergies in adults and kids 5 years and older.

Top FAERS reaction fields for azelastine total 9,158 reports across 10 reactions, set beside olopatadine nasal. Counts are exposure-weighted submissions, not per-patient risk.

About azelastine

Azelastine nasal spray is an antihistamine medicine. It helps relieve allergy and non-allergy nasal symptoms.

Used for: This medicine treats symptoms of seasonal allergies in adults and kids 5 years and older. It also treats symptoms of vasomotor rhinitis (stuffy or runny nose not caused by allergies) in adults and teens 12 years and older. It works by blocking histamine, a substance in the body that causes allergy symptoms.

1 Antihistamine (Nasal) peers (wide set)

Compare azelastine vs olopatadine nasal side-by-side →

azelastine vs olopatadine nasal · FAERS reaction fields

FAERS top-reaction field "Treatment Failure" shows the widest count spread between azelastine and olopatadine nasal in this extract (1,876-report gap on that field). Counts are exposure-weighted submissions, not prevalence rates.

Side Effect azelastine olopatadine nasal
Treatment Failure 1,876 -
Fatigue 1,144 -
Headache 883 -
Nausea 879 -
Dyspnoea 836 -
Diarrhoea 766 -
Pain 755 -
Cough 719 -

"-" means no reports for that reaction. Report counts reflect total FAERS submissions, not prevalence rates.

azelastine shortage vs Antihistamine (Nasal) peer index

Shortage status

FDA shortage listing is active for azelastine (status: To Be Discontinued). Peer rows remain a registry index, not a switch guide.

Frequently Asked Questions

Does FDA list a shortage for azelastine while peers remain indexed?
Yes - azelastine matched an active FDA shortage listing (To Be Discontinued) while 1 other Antihistamine (Nasal) SPL records remain in this peer index for field comparison only.

Registry note: Shortage listings and peer indexes are for registry orientation only. This information is for educational purposes only and is not a substitute for professional medical advice. Do not stop or change your medication without talking to your doctor or pharmacist.

Full azelastine profile →

Field note for azelastine: see also the generic vs brand label guide when reading Astelin SPL strings.